Kos Biotechnology Partners | Kos Biotechnology Fund

vc$123MCo-investsLeads rounds

◆ Fund Size

$123M

◆ Check Size

$1.0M→$50.0M

◆ Location

Greece

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Novel therapeutics, pharma services and technology-enabled life sciences platforms, connecting US biopharma development expertise with European scientific talent

◆ About Kos Biotechnology Partners

Kos Biotechnology Partners is a Greece-based venture capital firm dedicated to life sciences. It backs founders across biotech/novel therapeutics, pharma services, and tech-enabled technologies, and says it partners hands-on with global experts to build lasting companies.[4][1][2]

◆ Sectors

BiotechDrug DiscoveryDiagnosticsMedtechDigital Health

◆ Stages

pre-seedseedseries-aseries-bseries-c

◆ Geography Focus

EuropeGreeceUnited States

◆ Team

Name	Title	Role	Links
Alex Tzoukas	Co-Founder	partner	in
Dr. Simos Simeonidis	Founder / Managing Partner	partner
Nikos Kostaras	—	Partner	in
Simos Simeonidis	Founder / Managing Partner	Managing Partner	in

◆ Notable Investments

Epikastcompany formation through later-stage biotech and healthcare technology investments

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Kos Biotechnology Fund invest in?

Kos Biotechnology Fund invests in Biotech, Drug Discovery, Diagnostics, Medtech and Digital Health at the pre-seed, seed, series-a, series-b and series-c stages.

Which geographies does Kos Biotechnology Fund focus on?

Kos Biotechnology Fund focuses on Europe, Greece and United States, and is headquartered in Greece.

What is Kos Biotechnology Fund's typical check size?

Kos Biotechnology Fund typically writes checks of $1M to $50M.